Analysis of Canadian multiple sclerosis patients does not support a role for FKBP6 in disease

Abstract

Get full access to this article

View all access options for this article.

References

Mescheriakova

Verkerk

Amin

et al . Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family. Mult Scler 2019; 25(7): 909–917.

Sadovnick

Traboulsee

et al . Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis. Hum Mutat 2017; 38: 736–744.

Wang

Sadovnick

Traboulsee

et al . Nuclear receptor NR1H3 in familial multiple sclerosis. Neuron 2016; 90: 948–954.

Aasly

Vilarino-Guell

Dachsel

et al . Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson’s disease. Mov Disord 2010; 25: 2156–2163.

Abdelfatah

McComiskey

Doucette

et al . Identification of a novel in-frame deletion in KCNQ4 (DFNA2A) and evidence of multiple phenocopies of unknown origin in a family with ADSNHL. Eur J Hum Genet 2013; 21: 1112–1119.

Wang

Sadovnick

Traboulsee

et al . Case-control studies are not familial studies. Neuron 2016; 92: 339–341.

Traboulsee

Sadovnick

Encarnacion

et al . Common genetic etiology between ‘multiple sclerosis-like’ single-gene disorders and familial multiple sclerosis. Hum Genet 2017; 136:705–714.

Lek

Karczewski

Minikel

et al . Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536: 285–291.

Kircher

Witten

Jain

et al . A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014; 46: 310–315.

10.

Petersen

Fredrich

Hoeppner

et al . Opportunities and challenges of whole-genome and -exome sequencing. BMC Genet 2017;18: 14.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.24 MB